Farther Finance Advisors »

Leap Therapeutics shares owned by Farther Finance Advisors

Quarter-by-quarter ownership of Leap Therapeutics (CYPH) shares owned by Farther Finance Advisors from 13F filings

Historical chart of Farther Finance Advisors investment in Leap Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Leap Therapeutics held by Farther Finance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Leap Therapeutics by Farther Finance Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.4k 2.1k 1.16
2025-09-30 $454 1.0k 0.45
2025-06-30 $297 1.0k 0.30
2025-03-31 $291 1.0k 0.29

More positions owned by Farther Finance Advisors

Ishares Core S&p 500 Etf Etf (IVV)
Apple Stock (AAPL)
Vanguard S&p 500 Etf Etf (VOO)
Nvidia Corporation Stock (NVDA)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Dimensional International Value Etf Etf (DFIV)
Microsoft Corp Stock (MSFT)
Schwab U.s. Large-cap Etf Etf (SCHX)
Ishares 0-3 Month Treasury Bond Etf Etf (SGOV)
Amazon Stock (AMZN)
Invesco Qqq Trust Series I Etf (QQQ)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Vanguard Short-term Corporate Bond Etf Etf (VCSH)
Vanguard Value Etf Etf (VTV)

View all positions for Farther Finance Advisors

Top funds holding Leap Therapeutics

Gilead Sciences
Vanguard Group
HighTower Advisors
Simplify Asset Management
Geode Capital Management
Jane Street
State Street Corporation
BlackRock
Hrt Financial
Texas Capital Bank Wealth Management Services
Two Sigma Advisers
Susquehanna International
Key Client Fiduciary Advisors
Citadel Advisors
Two Sigma Investments

View all funds holding Leap Therapeutics